Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by Londonjeeveson Mar 28, 2021 7:38am
333 Views
Post# 32894367

Top BOD with Halyk & Martin (former CEO of Nestle Canada)!!!

Top BOD with Halyk & Martin (former CEO of Nestle Canada)!!!
It's a long play for me now at these silly low share price! 
Lately it received a cannabis drug license so it can now manufacture a medical drug with a DIN. 
It can now apply that license to its white label and manufacture medication for companies. 
Pharmaceutical giant Stada and the five-year partnership in Germany has already started! 
Australia has gone OTC on CBD. Great for the Australian facility, and being able to ship to the EU to fulfill contracts. 
 
Canadian facility recorded 555,000 units inQ4. 
 
Also, a rather very competent BOD with the addition of Chris Halyk of Johnson &Johnson / Janssen and Shelly Martin, former president & CEO of Nestle Canada.
 
Let´s hope that they find the right CEO, someone that will help them expand into the international pharmaceutical market.
 
PS: I'm sceptical about how investors will react to Q4 and Q1 earnings, however I do feel good about my investement in Mediparm in the long run.
 
PPS: I shall keep ready to deploy even more "dry powder" when the stock gets further down after Q4 and Q1 earnings.
<< Previous
Bullboard Posts
Next >>